Clover, Chengda IPOs Add To $1.2bn Raised By Chinese Bioventures

 
• By Dexter Jie Yan
  
fund raising
Chinese biotechs keep tapping into domestic capital market • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia